See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

Imperative Care expands Symphony thrombectomy portfolio with new US FDA approval - Interventional News

Summary by Interventional News
Symphony Imperative Care today announced US Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony 16Fr catheter, the company’s latest innovation designed to elevate care for patients with venous thrombosis. “Thrombectomy procedures have emerged as one of the most powerful treatments in medicine, restoring vital blood flow in minutes. Historically, peripheral vascular thrombectomy has lacked technologies that eff…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
DAICDAIC

Imperative Care Expands Precision Thrombectomy Portfolio

Thrombectomy system is designed to efficiently maximize clot removal with a focus on minimizing blood loss. The 82 cm version of its Symphony 16F catheter receives FDA 510(k) clearance.

Read Full Article
Interventional NewsInterventional News

Imperative Care expands Symphony thrombectomy portfolio with new US FDA approval - Interventional News

Symphony Imperative Care today announced US Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony 16Fr catheter, the company’s latest innovation designed to elevate care for patients with venous thrombosis. “Thrombectomy procedures have emerged as one of the most powerful treatments in medicine, restoring vital blood flow in minutes. Historically, peripheral vascular thrombectomy has lacked technologies that eff…

Read Full Article
Endovascular TodayEndovascular Today

New Length of Imperative Care’s Symphony Catheter Cleared by FDA - Endovascular Today

March 24, 2025—Imperative Care, Inc. announced FDA 510(k) clearance of the 82 cm version of its Symphony 16-F catheter for the treatment of venous thrombosis. The company also announced the successful completion of initial patient cases using the Symphony 16-F, 82-cm catheter. Bennet George, MD, an interventional cardiologist at Vital Heart & Vein in Houston, Texas, performed several of the initial procedures with the device. “In my early experi…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endovascular Today broke the news in on Monday, March 24, 2025.
Sources are mostly out of (0)

Similar News Topics

Innovation

Innovation

Houston, Texas

Houston, Texas

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal